Janux Therapeutics Employee Directory
Biotechnology ResearchCalifornia, United States51-200 Employees
Janux Therapeutics is a clinical-stage biotechnology company based in San Diego, California, focused on cancer immunotherapies. Its programs aim to induce tumor-specific immune responses that attack cancer cells while preserving healthy tissue. The company employs a platform masking approach to design candidates intended to overcome toxicity and efficacy limitations of traditional T cell engagers. The firm earned a Great Place to Work Certification in 2024. In 2026, Janux announced a collaboration with Bristol Myers Squibb to develop a novel tumor-activated therapeutic for solid tumors, accompanied by an exclusive worldwide license agreement. It also unveiled a 'double-masked' T cell engager, representing a recent milestone in its development program.